Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Gastrointest Endosc. 2019 May 22;90(3):495–501. doi: 10.1016/j.gie.2019.05.029

Table 1.

Patient and exam characteristics, stratified by index findings

Factors Index Colonoscopy Findings
Group 1 1–2 diminutive* adenomas Group 2 1–2 adenomas < 1 cm, one or more small** Group 3 3–10 diminutive* adenomas Group 4 3–10 adenomas < 1 cm, one or more small** Group 5 Advanced adenoma***
N 2568 1294 293 425 1503
Age (mean + S.D.) 59.1 ± 8.9 58.7 ± 9.5 62.5 ± 8.9 62.5 ± 9.1 60.0 ± 9.7
Sex (% male) 1387
(54.0%)
744
(57.5%)
204
(69.6%)
309
(72.7%)
890
(59.2%)
BMI 28.5 ± 5.9 28.6 ± 6.1 29.7 ± 6.7 29.9 ± 5.8 29.2 ± 6.1
Family history of CRC (first degree relative) 617
(24.0%)
305
(23.6%)
68
(23.2%)
92
(21.6%)
313
(20.8%)
Current smokers 239
(9.9%)
135 (10.17%) 39
(13.5%)
46
(11.2%)
211
(14.5%)
Aspirin use (regular) 995
(38.7%)
536
(41.4%)
115
(39.2%)
217
(51.1%)
556
(37.0%)
Alcohol (at least 5 drinks per week) 804
(31.3%)
384
(29.7%)
104
(35.5%)
129
(30.4%)
448
(29.8%)
Education (HS or more) 2383
(92.8%)
1207
(93.3%)
272
(92.8%)
389
(91.5%)
1379
(91.7%)
Regular exercise (at least 1/week) 1444
(56.2%)
699
(54.0%)
145
(49.5%)
217
(51.1%)
742 (49.4%)
Previous adenomas 795
(31.5)
388
(30.6%)
135
(48.0%)
197
(47.7%)
397
(27.0%)
Clinically significant serrated polyps**** at index exam 190
(7.5%)
138
(10.8%)
22
(7.6%)
42
(9.9%)
149
(11.3%)
Months to surveillance exam 57.9 ± 19.2 56.7 ± 12.1 42.5 ± 15.1 40.6 ± 16.0 38.6 ± 23.0
*

Diminutive = <5 mm;

**

Small = 5–9 mm;

***

Advanced adenomas: adenomas ≥1cm or those with villous elements, high-grade dysplasia, or CRC.

****

Clinically Significant serrated polyps: all SSA/Ps, TSAs, HPs >1 cm anywhere in the colon or any HP > 5mm in the proximal colon